We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
+20.94%
1 Year Est. Return
+80.99%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.51B
AUM Growth
+$540M
Cap. Flow
-$18.6M
Cap. Flow %
-0.34%
Top 10 Hldgs %
46.25%
Holding
691
New
31
Increased
112
Reduced
426
Closed
60

Top Buys

Rank Stock Value
1
LITE icon
Lumentum
LITE
+$33.3M
2
BE icon
Bloom Energy
BE
+$30.1M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$25M
4
SNDK
Sandisk
SNDK
+$23.5M
5
NBIS
Nebius Group N.V.
NBIS
+$22.4M

Top Sells

Rank Stock Value
1
BTI icon
British American Tobacco
BTI
+$36.2M
2
CLS icon
Celestica
CLS
+$21.9M
3
WMT icon
Walmart Inc
WMT
+$21.5M
4
UNH icon
UnitedHealth
UNH
+$20.7M
5
YUMC icon
Yum China
YUMC
+$14.8M

Sector Composition

Rank Sector Weight
1 Technology 48.98%
2 Communication Services 15.81%
3 Consumer Discretionary 13.07%
4 Healthcare 6.06%
5 Consumer Staples 4.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LXRX icon
551
Lexicon Pharmaceuticals
LXRX
$1.03B
$10.6K ﹤0.01%
+7,818
New +$8.87K
HCM icon
552
HUTCHMED
HCM
$1.96B
$10.5K ﹤0.01%
669
-125
-16% -$2.06K
RGNX icon
553
Regenxbio
RGNX
$616M
$10.5K ﹤0.01%
1,087
-182
-14% -$1.61K
INBX icon
554
Inhibrx
INBX
$1.16B
$10.3K ﹤0.01%
307
-52
-14% -$1.28K
SLDB icon
555
Solid Biosciences
SLDB
$792M
$10.3K ﹤0.01%
1,675
+684
+69% +$4K
INN
556
Summit Hotel Properties
INN
$766M
$10.3K ﹤0.01%
1,880
-59
-3% -$322
ABSI icon
557
Absci
ABSI
$1.17B
$9.78K ﹤0.01%
3,217
+276
+9% +$763
GLUE icon
558
Monte Rosa Therapeutics
GLUE
$1.82B
$9.76K ﹤0.01%
1,317
-255
-16% -$1.35K
GOOD
559
Gladstone Commercial Corp
GOOD
$623M
$9.51K ﹤0.01%
772
-23
-3% -$306
DSGN icon
560
Design Therapeutics
DSGN
$751M
$9.13K ﹤0.01%
1,213
-236
-16% -$1.18K
AHRT
561
AH Realty Trust
AHRT
$536M
$9.1K ﹤0.01%
1,298
-129
-9% -$915
MRVI icon
562
Maravai LifeSciences
MRVI
$972M
$8.93K ﹤0.01%
3,113
-518
-14% -$1.32K
ALX
563
Alexander's
ALX
$1.36B
$8.91K ﹤0.01%
38
-3
-7% -$705
WSR
564
DELISTED
Whitestone REIT
WSR
$8.9K ﹤0.01%
725
-53
-7% -$667
ATXS
565
DELISTED
Astria Therapeutics
ATXS
$8.8K ﹤0.01%
1,209
-235
-16% -$1.59K
FDMT icon
566
4D Molecular Therapeutics
FDMT
$502M
$8.73K ﹤0.01%
1,005
-142
-12% -$849
EOLS icon
567
Evolus
EOLS
$397M
$8.55K ﹤0.01%
1,392
-229
-14% -$1.79K
UHT
568
Universal Health Realty Income Trust
UHT
$621M
$8.54K ﹤0.01%
218
-19
-8% -$765
ALMS
569
Alumis Inc
ALMS
$3.36B
$8.31K ﹤0.01%
2,084
-324
-13% -$1.33K
PACB icon
570
Pacific Biosciences
PACB
$435M
$8.27K ﹤0.01%
6,462
-329
-5% -$446
AURA icon
571
Aura Biosciences
AURA
$725M
$8.26K ﹤0.01%
1,336
+57
+4% +$373
FPI
572
Farmland Partners
FPI
$415M
$8.05K ﹤0.01%
740
-31
-4% -$340
CBL
573
CBL Properties
CBL
$1.84B
$7.92K ﹤0.01%
259
-14
-5% -$408
LXEO icon
574
Lexeo Therapeutics
LXEO
$338M
$7.72K ﹤0.01%
1,162
+342
+42% +$1.65K
BCYC
575
Bicycle Therapeutics
BCYC
$269M
$7.7K ﹤0.01%
995
-131
-12% -$989
21 22
23
24 25

Similar funds

CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
BP
BC Partners New York $5.96B AUM 15.21% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.03B AUM 40.55% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return

GF Fund Management's Q3 2025 Portfolio in Review

As of Q3 2025, GF Fund Management held 691 positions worth $5.51B, up 11% from $4.97B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

GF Fund Management's Q3 2025 filing shows 31 new, 112 increased, 426 reduced and 60 closed positions. Its largest new stake was Bloom Energy: 648,856 shares worth $54.9M. The largest sale was British American Tobacco, an estimated $36.2M.

By sector, the portfolio is most concentrated in Technology at 49% of assets, up from 46% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • GF Fund Management's largest Q3 2025 buy was Bloom Energy: 648,856 shares worth $54.9M.
  • GF Fund Management added most to Lumentum in Q3 2025, an estimated $33.3M increase.
  • GF Fund Management's biggest Q3 2025 reduction was British American Tobacco, cutting an estimated $36.2M.
  • GF Fund Management fully exited Yum China in Q3 2025, selling an estimated $14.8M.
  • GF Fund Management's ten largest holdings make up 46% of its $5.51B portfolio in Q3 2025.
  • GF Fund Management opened 31 new positions and closed 60 in Q3 2025.
  • GF Fund Management's portfolio value rose 11% quarter-over-quarter to $5.51B.

Based on GF Fund Management's 13F filing for Q3 2025, filed 7 Nov 2025.